ARCHIVES

In Brief: Peck Joins GenPharm board; Dallas Hospital Selects director For New BMT Program

This article is from The Cancer Letter archive.

Vol. 20 No. 06 | February 11, 1994

Download PDF Visit The Full Archive

Related Articles

NCI Eases Some Cooperative Group Concern; DeVita Considers Other CCOP- Research Base Funding Option

April 2, 1982

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

August 1, 2014

Cancer Telethon Attracts Small Audience, Generates Expectations-And Questions.

September 12, 2008

New NIH Program To Develop Therapies For Rare, Neglected Diseases

June 19, 2009

In Congress: Senate Passes Bill For DOD Medical Research Funding

August 14, 1998

FDA Approves Inlyta Pill For Renal Cell Carcinoma

January 27, 2012